This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malbruny, B.
Right arrow Articles by Leclercq, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malbruny, B.
Right arrow Articles by Leclercq, R.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, July 2002, p. 2200-2207, Vol. 46, No. 7
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.7.2200-2207.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Resistance to Quinupristin-Dalfopristin Due to Mutation of L22 Ribosomal Protein in Staphylococcus aureus

Brigitte Malbruny,1 Annie Canu,2 Bülent Bozdogan,1 Bruno Fantin,3 Virginie Zarrouk,3 Sylvie Dutka-Malen,4 Celine Feger,4 and Roland Leclercq1*

Service de Microbiologie, CHU de Caen,1 UFR Pharmacie, Caen,2 INSERM EMI9933 and Bichat University, Paris,3 Anti-Infective Clinical Research, Aventis, Vitry-sur-Seine, France4

Received 29 October 2001/ Returned for modification 19 February 2002/ Accepted 3 April 2002

The mechanism of resistance to the streptogramin antibiotics quinupristin and dalfopristin was studied in a Staphylococcus aureus clinical isolate selected under quinupristin-dalfopristin therapy, in four derivatives of S. aureus RN4220 selected in vitro, and in a mutant selected in a model of rabbit aortic endocarditis. For all strains the MICs of erythromycin, quinupristin, and quinupristin-dalfopristin were higher than those for the parental strains but the MICs of dalfopristin and lincomycin were similar. Portions of genes for domains II and V of 23S rRNA and the genes for ribosomal proteins L4 and L22 were amplified and sequenced. All mutants contained insertions or deletions in a protruding ß hairpin that is part of the conserved C terminus of the L22 protein and that interacts with 23S rRNA. Susceptible S. aureus RN4220 was transformed with plasmid DNA encoding the L22 alteration, resulting in transformants that were erythromycin and quinupristin resistant. Synergistic ribosomal binding of streptogramins A and B, studied by analyzing the fluorescence kinetics of pristinamycin IA-ribosome complexes, was abolished in the mutant strain, providing an explanation for quinupristin-dalfopristin resistance.


* Corresponding author. Mailing address: CHU de Caen, Service de Microbiologie, Avenue Côte de Nacre, 14033 Caen Cedex, France. Phone: (33) 02 31 06 45 72. Fax: (33) 02 31 06 45 73. E-mail: leclercq-r{at}chu-caen.fr.


Antimicrobial Agents and Chemotherapy, July 2002, p. 2200-2207, Vol. 46, No. 7
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.7.2200-2207.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Gentry, D. R., Holmes, D. J. (2008). Selection for High-Level Telithromycin Resistance in Staphylococcus aureus Yields Mutants Resulting from an rplB-to-rplV Gene Conversion-Like Event. Antimicrob. Agents Chemother. 52: 1156-1158 [Abstract] [Full Text]  
  • Hmouda, H., Ben Salem, C., Bouraoui, K., Jemni, L. (2007). Treatment of MRSA Infections With Older Molecules: A Reasonable Option for Investigation. Arch Intern Med 167: 1207-1208 [Full Text]  
  • Cagliero, C., Mouline, C., Cloeckaert, A., Payot, S. (2006). Synergy between Efflux Pump CmeABC and Modifications in Ribosomal Proteins L4 and L22 in Conferring Macrolide Resistance in Campylobacter jejuni and Campylobacter coli. Antimicrob. Agents Chemother. 50: 3893-3896 [Abstract] [Full Text]  
  • Friedman, L., Alder, J. D., Silverman, J. A. (2006). Genetic Changes That Correlate with Reduced Susceptibility to Daptomycin in Staphylococcus aureus.. Antimicrob. Agents Chemother. 50: 2137-2145 [Abstract] [Full Text]  
  • Dupuis, M., Leclercq, R. (2006). Activity of a New Oral Streptogramin, XRP2868, against Gram-Positive Cocci Harboring Various Mechanisms of Resistance to Streptogramins. Antimicrob. Agents Chemother. 50: 237-242 [Abstract] [Full Text]  
  • Bogdanovich, T., Ednie, L. M., Shapiro, S., Appelbaum, P. C. (2005). Antistaphylococcal Activity of Ceftobiprole, a New Broad-Spectrum Cephalosporin. Antimicrob. Agents Chemother. 49: 4210-4219 [Abstract] [Full Text]  
  • Rolain, J. M., Raoult, D. (2005). Prediction of resistance to erythromycin in the genus Rickettsia by mutations in L22 ribosomal protein. J Antimicrob Chemother 56: 396-398 [Abstract] [Full Text]  
  • Vouillamoz, J., Entenza, J. M., Hohl, P., Moreillon, P. (2004). LB11058, a New Cephalosporin with High Penicillin-Binding Protein 2a Affinity and Activity in Experimental Endocarditis Due to Homogeneously Methicillin-Resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 48: 4322-4327 [Abstract] [Full Text]  
  • Hmouda, H., Jemni, L. (2004). Comment: trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections. The Annals of Pharmacotherapy 38: 1970-1971 [Full Text]  
  • Peric, M., Bozdogan, B., Galderisi, C., Krissinger, D., Rager, T., Appelbaum, P. C. (2004). Inability of L22 ribosomal protein alteration to increase macrolide MICs in the absence of efflux mechanism in Haemophilus influenzae HMC-S. J Antimicrob Chemother 54: 393-400 [Abstract] [Full Text]  
  • Achour, W., Guenni, O., Malbruny, B., Canu, A., Leclercq, R., Ben Hassen, A. (2004). Phenotypic and molecular characterization of macrolide and streptogramin resistance in Streptococcus mitis from neutropenic patients. J Antimicrob Chemother 54: 117-121 [Abstract] [Full Text]  
  • Adra, M., Lawrence, K. R (2004). Trimethoprim/Sulfamethoxazole for Treatment of Severe Staphylococcus aureus Infections. The Annals of Pharmacotherapy 38: 338-341 [Abstract] [Full Text]  
  • Canu, A., Abbas, A., Malbruny, B., Sichel, F., Leclercq, R. (2004). Denaturing High-Performance Liquid Chromatography Detection of Ribosomal Mutations Conferring Macrolide Resistance in Gram-Positive Cocci. Antimicrob. Agents Chemother. 48: 297-304 [Abstract] [Full Text]  
  • Jones, R. N., Farrell, D. J., Morrissey, I. (2003). Quinupristin-Dalfopristin Resistance in Streptococcus pneumoniae: Novel L22 Ribosomal Protein Mutation in Two Clinical Isolates from the SENTRY Antimicrobial Surveillance Program. Antimicrob. Agents Chemother. 47: 2696-2698 [Abstract] [Full Text]  
  • Farrell, D. J., Douthwaite, S., Morrissey, I., Bakker, S., Poehlsgaard, J., Jakobsen, L., Felmingham, D. (2003). Macrolide Resistance by Ribosomal Mutation in Clinical Isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 Study. Antimicrob. Agents Chemother. 47: 1777-1783 [Abstract] [Full Text]  
  • Haroche, J., Morvan, A., Davi, M., Allignet, J., Bimet, F., El Solh, N. (2003). Clonal Diversity among Streptogramin A-Resistant Staphylococcus aureus Isolates Collected in French Hospitals. J. Clin. Microbiol. 41: 586-591 [Abstract] [Full Text]  
  • Johnson, A. P., Woodford, N. (2002). Glycopeptide-resistant Staphylococcus aureus. J Antimicrob Chemother 50: 621-623 [Full Text]  
  • Prunier, A.-L., Malbruny, B., Tande, D., Picard, B., Leclercq, R. (2002). Clinical Isolates of Staphylococcus aureus with Ribosomal Mutations Conferring Resistance to Macrolides. Antimicrob. Agents Chemother. 46: 3054-3056 [Abstract] [Full Text]